Stryker SYK MedSurg and Neurotechnology: — Selling, general and administrative expenses

Other segment segments

Similar metrics at other companies

LEASeating — Selling, general and administrative expenses

$97.9M+14.5%

KNFCentral — Selling, general and administrative expenses

$23.27M+26.0%

AMRCU.S. Federal — Selling, general and administrative expenses

$4.77M+74.5%

TRCMineral resources — Selling, general and administrative expenses

$96K-48.9%

TPRCoach — Selling, general and administrative expenses

$743.8M+24.3%

AMRCEurope — Selling, general and administrative expenses

$6.33M+27.2%

FAQ

What is Stryker's medsurg and neurotechnology: — selling, general and administrative expenses?

Stryker (SYK) reported medsurg and neurotechnology: — selling, general and administrative expenses of $930M in Q1 2026.

How has Stryker's medsurg and neurotechnology: — selling, general and administrative expenses changed year-over-year?

Stryker's medsurg and neurotechnology: — selling, general and administrative expenses increased by 8.3% year-over-year, from $859M to $930M.

What is the long-term trend for Stryker's medsurg and neurotechnology: — selling, general and administrative expenses?

Over 3 years (2022 to 2025), Stryker's medsurg and neurotechnology: — selling, general and administrative expenses has grown at a 14.5% compound annual growth rate (CAGR), from $2.56B to $3.85B.

What does medsurg and neurotechnology: — selling, general and administrative expenses mean?

Encompasses the overhead costs required to operate the MedSurg and Neurotechnology segment, including sales force commissions, marketing, legal, and general administrative support. This metric measures the operational efficiency of the segment's commercial and support functions. It is a key factor in determining the segment's overall operating margin.